LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway
Cell Biology International · 2026
DOI: 10.1002/cbin.70118 ↗At a glance
Journal article in Cell Biology International, 2026. Written by Chengli Qian and 6 co-authors. Institution: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China. Major MEDLINE topics: Apoptosis, Receptors, N-Methyl-D-Aspartate, Neurons, Mitochondria. 41 references. Funded by: National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation, Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University.
Abstract (original language)
Brain ischemia induces neuronal apoptosis, a key event in stroke pathology, but the underlying mechanisms remain incompletely understood. This study investigates the role of the volume‐regulated anion channel subunit leucine‐rich repeat‐containing protein 8 A (LRRC8A) in ischemia‐induced neuronal damage. In a rat model of middle cerebral artery occlusion (MCAO) and in cultured neurons under oxygen‐glucose deprivation (OGD), ischemia/hypoxia rapidly upregulated LRRC8A expression in apoptotic neurons. Knockdown of lrrc8a via small interfering RNA (siRNA) attenuated brain infarction, improved neurological deficits, and reduced neuronal apoptosis. Mechanistically, lrrc8a knockdown suppressed the activation of the mitochondrial Bax/Bcl‐2/Caspase‐9/Caspase‐3 apoptotic pathway. Furthermore, lrrc8a knockdown reversed OGD‐induced hyperactivation of NMDA receptors (NMDARs) and weakened the enhanced interaction between LRRC8A and the obligatory NMDAR subunit GluN1, which was predicted by structural modeling. These findings reveal that cerebral ischemia upregulates neuronal LRRC8A, which may promote NMDAR hyperactivity via interaction with GluN1, thereby triggering mitochondrial apoptosis. LRRC8A represents a potential therapeutic target for mitigating neuronal apoptosis in ischemic stroke.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Hubei Polytechnic Institute, School of Medical Science, Xiaogan, Hubei, China.
- Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China.
- College of Life Sciences, South-Central University for Nationalities, Wuhan, Hubei, China.
Funding
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
- Medical Sci-Tech Innovation Platform of Zhongnan Hospital, Wuhan University
- Science and Technology Innovation Cultivation Fund of Zhongnan Hospital, Wuhan University
Cite
APA
Qian, C., Huang, L., Chen, Y., Lv, J., Wang, Z., Dai, J., & Luo, Y. (2026). LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway. Cell Biology International. https://doi.org/10.1002/cbin.70118
Vancouver
Qian C, Huang L, Chen Y, Lv J, Wang Z, Dai J, et al. LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway. Cell Biology International. 2026. doi:10.1002/cbin.70118
BibTeX
@article{Qian2026,
author = {Qian, Chengli and Huang, Linshu and Chen, Ying and Lv, Jianghao and Wang, Zhuo and Dai, Jiapei and Luo, Yi},
title = {LRRC8A Mediates Ischemic Neuronal Injury by Potentiating NMDA Receptor Activity and Activating Mitochondrial Apoptotic Pathway},
journal = {Cell Biology International},
year = {2026},
doi = {10.1002/cbin.70118}
}
EUVIMED